Skip to content

Public FDA record

Z-0742-2022: VIDAS CMV IgM, 30 tests, REF 30205-01, IVD, Rx.

Recall record Z-0742-2022 for bioMerieux, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0742-2022
Company in FDA record
bioMerieux, Inc.
FDA classification date
Mar 14, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Invalid calibrations (out of range high) while using the product.

Source facts

Action
The recalling firm issued letters dated 2/9/2022 via Fed Ex Express Priority Overnight delivery service to their U.S. consignees. The letter described the issue, the impact to the user, and the required actions. Those actions included instructing the consignee to stop using and destroy any stock of the recalled lot and to complete the Acknowledgement Form and return it via email or FAX. The quantity discarded was to be completed on the Acknowledgement Form.
Initiated
2022-02-09
Root cause
Nonconforming Material/Component
Terminated
2026-04-01
Distribution
Distribution was made to CA, FL, GA, IL, IN, LA, MA, MD, ME, MO, NJ, NY, OH, PA, TX, VA, WI, and WV. There was government distribution but no military or foreign distribution.
Recall number
Z-0742-2022
Recall status
Terminated
CDRH record ID
191956
FDA classified
2022-03-14
Recall event number
89568

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗